The new guidelines have been written to help clinicians in the network follow clear, consistent and evidence-based referral pathways for patients with blood cancers. In doing so we will able to provide more consistent approaches to treatment and reduce unwarranted variations in care, ultimately helping to improve patient outcomes on a wider scale.

The guidelines may be accessed via the links below.

Pan London Acute Lymphoblastic Leukaemia (ALL) guidelines

Pan London Acute Myeloid Leukaemia (AML) guidelines

Pan London Chronic Myeloid Leukaemia (CML) guidelines

Pan London Chronic Lymphocytic Leukaemia (CLL) guidelines

Pan London Diffuse Large B-Cell Lymphoma (DLBCL) guidelines

Pan London Follicular Lymphoma (FL) guidelines

Pan London Hodgkin Lymphoma guidelines

Pan London Less Common Blood Cancer guidelines

Pan London Myelodysplastic Syndromes (MDS) guidelines

Pan London Myeloproliferative Neoplasms (MPN) guidelines

Pan London Plasma Cell guidelines

Accessibility tools

Return to header